- Home
- HYB vs CBUS Comparison
HYB vs CBUS Comparison
Compare HYB & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYB
- CBUS
- Stock Information
- Founded
- HYB 1987
- CBUS 2010
- Country
- HYB United States
- CBUS United States
- Employees
- HYB N/A
- CBUS N/A
- Industry
- HYB Investment Managers
- CBUS Agricultural Chemicals
- Sector
- HYB Finance
- CBUS Industrials
- Exchange
- HYB Nasdaq
- CBUS Nasdaq
- Market Cap
- HYB 191.2M
- CBUS 120.1M
- IPO Year
- HYB 1999
- CBUS 2017
- Fundamental
- Price
- HYB $8.23
- CBUS $2.44
- Analyst Decision
- HYB
- CBUS Strong Buy
- Analyst Count
- HYB 0
- CBUS 3
- Target Price
- HYB N/A
- CBUS $22.83
- AVG Volume (30 Days)
- HYB 39.6K
- CBUS 229.3K
- Earning Date
- HYB 01-01-0001
- CBUS 11-07-2024
- Dividend Yield
- HYB 6.67%
- CBUS N/A
- EPS Growth
- HYB N/A
- CBUS N/A
- EPS
- HYB N/A
- CBUS N/A
- Revenue
- HYB N/A
- CBUS $4,152,999.00
- Revenue This Year
- HYB N/A
- CBUS $132.42
- Revenue Next Year
- HYB N/A
- CBUS $97.96
- P/E Ratio
- HYB N/A
- CBUS N/A
- Revenue Growth
- HYB N/A
- CBUS 449.34
- 52 Week Low
- HYB $6.23
- CBUS $2.17
- 52 Week High
- HYB $7.41
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- HYB 51.78
- CBUS 36.14
- Support Level
- HYB $8.14
- CBUS $2.17
- Resistance Level
- HYB $8.29
- CBUS $3.31
- Average True Range (ATR)
- HYB 0.07
- CBUS 0.35
- MACD
- HYB 0.01
- CBUS -0.00
- Stochastic Oscillator
- HYB 66.67
- CBUS 24.02
About HYB New America High Income Fund Inc. (The)
New America High Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide high current income while seeking to preserve stockholder capital by investing in a diversified portfolio of high-yield fixed-income securities. The Fund has a leveraged capital structure. The fund invests in fixed-maturity corporate debt securities that are rated less than the investment grade. Its portfolio of investment consists of investments in different sectors such as energy, financial, cable operators, healthcare, and others.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.